We are live on ! Find out more
TD Asset Management

TD Asset Management Portfolio holdings

AUM $123B
1-Year Est. Return 34.51%
This Fund
S&P 500
This Quarter Est. Return
+1.81%
1 Year Est. Return
+34.51%
3 Year Est. Return
+98.94%
5 Year Est. Return
+122.3%
10 Year Est. Return
+375.56%
AUM
$113B
AUM Growth
-$291M
Cap. Flow
-$147M
Cap. Flow %
-0.13%
Top 10 Hldgs %
26.07%
Holding
1,436
New
51
Increased
634
Reduced
495
Closed
194

Top Buys

Rank Stock Value
1
BKLN icon
Invesco Senior Loan ETF
BKLN
+$393M
2
ARES icon
Ares Management
ARES
+$218M
3
SAP icon
SAP
SAP
+$212M
4
LRCX icon
Lam Research
LRCX
+$196M
5
AAPL icon
Apple
AAPL
+$148M

Top Sells

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$293M
2
TD icon
Toronto Dominion Bank
TD
+$260M
3
ABBV icon
AbbVie
ABBV
+$184M
4
INTU icon
Intuit
INTU
+$111M
5
CRBG icon
Corebridge Financial
CRBG
+$103M

Sector Composition

Rank Sector Weight
1 Technology 21.96%
2 Financials 20.89%
3 Industrials 10.1%
4 Healthcare 9.35%
5 Consumer Discretionary 7.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALEC icon
1226
Alector
ALEC
$168M
$211K ﹤0.01%
111,738
CGC
1227
Canopy Growth
CGC
$387M
$210K ﹤0.01%
76,510
+1,131
+2% +$4.49K
PRLD icon
1228
Prelude Therapeutics
PRLD
$366M
$205K ﹤0.01%
160,652
HSTM icon
1229
HealthStream
HSTM
$819M
$204K ﹤0.01%
6,400
-1,700
-21% -$52.5K
CABA icon
1230
Cabaletta Bio
CABA
$437M
$201K ﹤0.01%
88,600
ANAB icon
1231
AnaptysBio
ANAB
$1.58B
$185K ﹤0.01%
14,000
-48,000
-77% -$1.16M
CLYM
1232
Climb Bio
CLYM
$681M
$161K ﹤0.01%
89,400
FRO icon
1233
Frontline
FRO
$8.76B
$145K ﹤0.01%
10,547
+364
+4% +$6.82K
MGNX icon
1234
MacroGenics
MGNX
$235M
$141K ﹤0.01%
43,400
-125,600
-74% -$452K
DAWN
1235
DELISTED
Day One Biopharmaceuticals
DAWN
$137K ﹤0.01%
10,796
PRME icon
1236
Prime Medicine
PRME
$527M
$136K ﹤0.01%
46,434
DNA icon
1237
Ginkgo Bioworks
DNA
$528M
$128K ﹤0.01%
13,046
HAFN icon
1238
Hafnia
HAFN
$3.84B
$110K ﹤0.01%
20,514
+2,542
+14% +$15.1K
CRON
1239
Cronos Group
CRON
$1.06B
$24.8K ﹤0.01%
+12,350
New +$25.8K
RVMDW icon
1240
Revolution Medicines Inc Warrant
RVMDW
$106M
$6.57K ﹤0.01%
40,636
WGSWW
1241
DELISTED
GeneDx Holdings Warrant
WGSWW
$5.58K ﹤0.01%
34,884
SONDW
1242
DELISTED
Sonder Holdings Inc Warrants
SONDW
$1.08K ﹤0.01%
180,000
AAL icon
1243
American Airlines Group
AAL
$10.1B
-190,900
Closed -$2.21M
AAP icon
1244
Advance Auto Parts
AAP
$3.35B
-54,768
Closed -$2.27M
ABCB icon
1245
Ameris Bancorp
ABCB
$5.85B
-3,500
Closed -$215K
ABM icon
1246
ABM Industries
ABM
$2.81B
-18,900
Closed -$971K
ABOS icon
1247
Acumen Pharmaceuticals
ABOS
$155M
-139,206
Closed -$345K
ACIW icon
1248
ACI Worldwide
ACIW
$5.83B
-12,900
Closed -$648K
ACLS icon
1249
Axcelis
ACLS
$4.01B
-14,900
Closed -$1.6M
ADUS icon
1250
Addus HomeCare
ADUS
$2.16B
-17,800
Closed -$2.33M

Similar funds

TD Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, TD Asset Management held 1,436 positions worth $113B, down 0.26% from $113B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

TD Asset Management's Q4 2024 filing shows 51 new, 634 increased, 495 reduced and 194 closed positions. Its largest new stake was Invesco Senior Loan ETF: 18,628,261 shares worth $392M. The largest sale was KLA, an estimated $293M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.

  • TD Asset Management's largest Q4 2024 buy was Invesco Senior Loan ETF: 18,628,261 shares worth $392M.
  • TD Asset Management added most to Ares Management in Q4 2024, an estimated $218M increase.
  • TD Asset Management's biggest Q4 2024 reduction was KLA, cutting an estimated $293M.
  • TD Asset Management fully exited Mueller Industries in Q4 2024, selling an estimated $25M.
  • TD Asset Management's ten largest holdings make up 26% of its $113B portfolio in Q4 2024.
  • TD Asset Management opened 51 new positions and closed 194 in Q4 2024.
  • TD Asset Management's portfolio value fell 0.26% quarter-over-quarter to $113B.

Based on TD Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.